Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Immune Network Research reacquires 1F7 AIDS antibody

Dec. 29, 1999

Glaxo Wellcome files for approval of first triple combination anti-HIV therapy

Dec. 20, 1999

Nonpeptide agents which mimic peptide T binding to CD4 cell receptors as new treatments for HIV

Dec. 20, 1999

Vertex/Glaxo Wellcome amprenavir prodrug receives fast track status

Dec. 17, 1999

2,5-Pyridinedicarboxylic acid derivatives from Dong Wha inhibit retrovirus RT

Dec. 16, 1999

Viral chimeras for stimulating anti-HIV-1 immune response

Dec. 15, 1999

FDA requires additional phase III studies for Coactinon

Dec. 14, 1999

HIV-VAC's AIDS vaccine progressing in clinical trials in Russia

Dec. 13, 1999

Hughes team reports advances in anti-HIV drug development

Dec. 9, 1999

Gilead terminates U.S. development of adefovir dipivoxil for HIV

Dec. 7, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...